[Search]
[by date] [by subject] [by continent]

NMR Technologies: Development and Applications for Drug Design and Characterization

Harborcourt Hotel , Baltimore, MD
October 29-30, 1998

Invited Speakers: Chairpersons:

Dr. Paul A. Keifer
Varian NMR Instruments

Dr. Ming-Daw Tsai
The Ohio State University

Additional Speakers:

Dr. Michael Andrec
Rutgers University

Dr. Ad Bax
National Institute of Diabetes and Digestive and Kidney Diseases, NIH

Dr. Joel Berendzen
Los Alamos National Laboratory

Dr. Wayne Fairbrother
Genentech, Inc.

Dr. Bennett T. Farmer II
Bristol-Myers Squibb Pharmaceutical Research Institute

Dr. Joel R. Garbow
Monsanto Company

Dr. Joyce Prosser James
Bruker Instruments

Dr. Kelly A. Keating
Pacific Northwest National Laboratory

Dr. Paul A. Keifer
Varian NMR Instruments

Dr. John L. Markley
University of Wisconsin, Madison

Dr. Jonathan M. Moore
Vertex Pharmaceuticals Incorporated

Dr. James D. Myers
Pacific Northwest National Laboratory

Dr. Stanley J. Opella
University of Pennsylvania

Dr. Art Palmer
Columbia University

Dr. Charles Sanders
Case Western Reserve University

Dr. John Shockcor
DuPont Merck and University of London

Dr. Michael F. Summers
University of Maryland, Baltimore County

Dr. Ming-Daw Tsai
The Ohio State University

Dr. Andrew Webb
University of Illinois at Urbana-Champaign

Program:
Session: Improvements in NMR Technologies
New Technical Developments in NMR
Perdeuteration and Selective Protonation in Solution-State Structural Studies
NMR Microprobes for High-Resolution Studies
Accurate Estimation of Global Dynamic Parameters from NMR Relaxation Data

Session: Sharing Resources and Facilities (in a starburst or flag): Plus Live Internet Demonstration)
Developing Tools for Streamlining Operations of a Shared Facility
Remote Research Using the EMSL Virtual NMR Facility

Session: Structural and Dynamic Analyses of Proteins and New Drug Targets
NMR Studies of HIV-1 Genome Recognition
Structure-Function Analysis of the INK4 Family of Tumor Suppressors
Studies of Protein Dynamics Using NMR
Sample Optimization Strategies for Membrane Proteins
NMR Structural Studies of Membrane Proteins
High-Throughput Crystallography and Structural Genomics
NMR Studies of Novel Phage-Derived Peptide Antagonists of Protein:Protein Interactions

Session: NMR for Drug Discovery
New NMR Technologies for Drug Discovery
The SHAPES Strategy: An NMR-Based Approach for Lead Generation in Drug Discovery
Development and Applications of HPLC, NMR, and HPLC-NMR/MS to Drug Discovery
The Identification of Bulk Drug Impurities Using LC-NMR Spectroscopy

Registration :
Advance Registration (by September 18, 1998): commercial-$845, academic-$395
On-Site Registration: commercial: $945 academic-$445
Students and Fellows: contact producer

Deadline for Abstracts: September 18, 1998

Email for Requests and Registration: csussman@healthtech.com


Posted by: Carol A. Ghatak Host: 207.60.238.22 date: July 20, 1998 17:30:54
Generated by meetings and positions 1.0 by Kai Garlipp